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background:  Stroke has emerged as an ominous complication after transcatheter aortic valve replacement. While short-term stroke risk 
of this procedure has been studied, long-term stroke risk with different valve types is not defined. We performed a comprehensive meta-
analysis to compare long-term risk of two commonly used transcatheter aortic valves.
methods:  We searched SCOPUS since inception to July 2014 using predefined criteria. Sixteen studies were eligible for our analysis. 
Standard meta-analytic methods were used to compare stroke rates among Edwards-SAPIEN (ES) and CoreValve (CV) groups at long-
term follow up.
results:  Among 8 studies, 4,480 ES valves were implanted in 4,542 patients. In the CV group, among 8 studies 1,408 valves were 
implanted in 1,409 patients. Patients were followed for 5,377 person years in ES vs 2276 person years in CV group. Mean follow was 1.7 
years (1-3.8 years) in ES group and 1.4 years (1-2.6 years) in the CV group. During the follow up, stroke rate in the ES group was 4.5% 
(95% CI: 3.3-6.2) vs 6.5% (95% CI: 3.9-10.7) in the CV group, p=0.247. (Figure 1)
Conclusion:  Our analysis suggests that both Edwards-SAPIEN and CoreValve have similar stroke rates over long term follow up.
 
